[
    [
        {
            "time": "",
            "original_text": "天风证券维持华大基因持有评级：常规业务恢复较高增长，持续推进全基因检测布局",
            "features": {
                "keywords": [
                    "天风证券",
                    "华大基因",
                    "持有评级",
                    "常规业务",
                    "较高增长",
                    "全基因检测",
                    "布局"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物科技",
                    "基因检测"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "天风证券维持华大基因持有评级：常规业务恢复较高增长，持续推进全基因检测布局",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        }
    ]
]